Mitochondrial Drugs for Alzheimer Disease
Therapeutic strategies for Alzheimer disease (AD) have yet to offer a diseasemodifying effect to stop the debilitating progression of neurodegeneration and cognitive decline. Rather, treatments thus far are limited to agents that slow disease progression without halting it, and although much work to...
Main Authors: | Xiongwei Zhu, Mark A. Smith, Katarzyna A. Gustaw-Rothenberg, George Perry, Xinglong Wang, David J. Bonda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2009-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/2/3/287/ |
Similar Items
-
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
by: Anil eKumar, et al.
Published: (2015-09-01) -
The Maintenance of Mitochondrial DNA Integrity and Dynamics by Mitochondrial Membranes
by: James Chapman, et al.
Published: (2020-08-01) -
The Concerted Action of Mitochondrial Dynamics and Positioning: New Characters in Cancer Onset and Progression
by: Diana Pendin, et al.
Published: (2017-05-01) -
Morphological Pathways of Mitochondrial Division
by: Bernard Tandler, et al.
Published: (2018-02-01) -
The role of mitochondrial dysfunction in Alzheimer’s disease
by: N. N. Koberskaya
Published: (2019-08-01)